Fortis hospital is the leading network of India's broad-based hospitals that have international accreditation of JCI and the quality mark of the National Council for the Certification of Hospitals and Medical Institutions in India - NABH.
In the global study "topmastersinhealthcare.com" of the thirty most state of the art centers globally, the Fortis Memorial Research Institute (FMRI) took the 2nd place.
The first network clinic, Fortis Mohali was founded in 2001, it become India's pioneer in the field of knee replacement, the treatment of aortic aneurysm, tumor surgery, congenital diaphragmatic hernia, removal of kidney tumors and complex cancer therapy.
In 2007, Fortis Hospital Mohali (FHM) was accredited by the Joint International Commission for the Quality and Safety of Medical Services (JCI). The Commission carries out repeated inspections every 3 years. The Fortis clinic was re-certified by JCI in 2010, 2013 and 2016.
In 2014, the Fortis Escorts Heart Institute became the "Best Private Cardiology Hospital in India" according to the Week magazine and the "Best provider of comprehensive cardiac care in India" from Frost & Sullivan.
The Cancer Institute of the Fortis Clinic India (FCI) opened in 2014. Thanks to advanced methods of treatment and new generation technologies, it quickly became one of the leading cancer centers.
The Cancer Cure Program in FCI provides for collegial acceptance of the diagnosis and the prescription of the most appropriate treatment regimen by the oncological Council. The council consists of clinical oncologists, oncology surgeons and radiation oncologists.
Cancer treatment in India is most often preferred at the Fortis Clinic, which is facilitated with an advanced linear VMAT accelerator. It irradiates the tumor with a mm accuracy and minimizes the effects of radiation on healthy tissues and organs. The device allows to destroy the maximum number of cancer cells with a large dose of radiation and at the same time reduce the duration of the intervention.
In addition, the cancer units of Fortis has Siemens Biograph Truepoint equipment with HD PET-CT, which detects malignant formations up to 1 mm in size.